Takeda's Suit Targeting Rival Gout Drug Is Dismissed
A Delaware federal judge on Wednesday tossed Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing its patents through the competing gout drug Mitigare,...To view the full article, register now.
Already a subscriber? Click here to view full article